SAHIB MAHARAJA K,AMBULGE JEETENDRA KASHINATH,AGRAWAL GAURAVKUMAR RAMANLAL
申请号:
IN2180/MUM/2014
公开号:
IN2014MU02180A
申请日:
2014.07.04
申请国别(地区):
IN
年份:
2016
代理人:
摘要:
The present invention provides a pharmaceutical formulation comprising from about 40IU to 200IU of an insulin analogue, derivative or metabolite having isoelectric point between 5.8 to 8.5, zinc or salts thereof, isotonic agent optionally along with one or more pharmaceutically acceptable excipients, wherein the formulation exhibits an extended release profile for a period of more than 24h.